Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
8.49
-0.25 (-2.86%)
Nov 2, 2026, 4:00 PM EST - Market closed
Benitec Biopharma Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Benitec Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $23.29. The average 1-year stock price forecast is 174.32% higher than the current stock price, while the lowest is $17 (+100.24%) and the highest is $32 (+276.91%).
Price Target: $23.29 (+174.32%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Benitec Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 7 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $32 | Buy | Reiterates | $32 | +276.91% | Nov 2, 2026 |
| Wedbush | Wedbush | Buy Maintains $16 → $17 | Buy | Maintains | $16 → $17 | +100.24% | Oct 28, 2026 |
| Raymond James | Raymond James | Buy Initiates $14 | Buy | Initiates | $14 | +64.90% | Oct 23, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 16, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $25 | Buy | Maintains | $25 | +194.46% | Sep 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
6.29
EPS Next Year
23.12
from 6.29
Increased by 267.57%
EPS and Forward PE are based on non-GAAP adjusted numbers.